Human central nervous system and plasma pharmacology of mitoxantrone

Mitoxantrone 5-6 mg/m2 was administered IV to 10 consenting patients prior to surgical resection of an intracerebral tumor. Plasma pharmacokinetic parameters were calculated and concentration of mitoxantrone in intracerebral tumors was determined. Concentrations of mitoxantrone were also determined...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuro-oncology 1988-05, Vol.6 (1), p.75-83
Main Authors: GREEN, R. M, STEWART, D. J, HUGENHOLTZ, H, RICHARD, M. T, THIBAULT, M, MONPETIT, V
Format: Article
Language:English
Subjects:
Adult
Aged
Antineoplastic agents
Autopsy
Biological and medical sciences
Brain Neoplasms - drug therapy
Brain Neoplasms - metabolism
Chemotherapy
Half-Life
Humans
Medical sciences
Middle Aged
Mitoxantrone - pharmacokinetics
Mitoxantrone - therapeutic use
Pharmacology. Drug treatments
Tissue Distribution
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mitoxantrone 5-6 mg/m2 was administered IV to 10 consenting patients prior to surgical resection of an intracerebral tumor. Plasma pharmacokinetic parameters were calculated and concentration of mitoxantrone in intracerebral tumors was determined. Concentrations of mitoxantrone were also determined in autopsy tissues of one of the patients who expired 192 days after receiving the drug. The plasma pharmacokinetics were best described by a 3 compartment model, with a tl/2 gamma of 4.74 +/- 5.53 h. Mitoxantrone concentrations in the intracerebral tumors were potentially cytotoxic and ranged from 4 to 322 ng/g. In all but one case, mitoxantrone concentration was higher in tumor than in concurrent plasma samples. There was no obvious relation between tumor mitoxantrone concentration and peak plasma mitoxantrone concentration or time from mitoxantrone administration to tumor removal. Low grade gliomas and viable tumors tended to have lower mitoxantrone concentrations than did other tumor types and necrotic tumors. In the patient undergoing autopsy, highest mitoxantrone concentrations were found in liver, thyroid and heart.
ISSN:0167-594X
1573-7373
DOI:10.1007/BF00163544